These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 39040355)

  • 1. The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: A systematic review and meta-analysis.
    Li C; Zhang J; Yang P; Wang R; Chen T; Li L
    Heliyon; 2024 Jul; 10(13):e33735. PubMed ID: 39040355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of polymyxin B-immobilized hemoperfusion against sepsis and septic shock: A systematic review and meta-analysis.
    Li X; Liu C; Mao Z; Qi S; Song R; Zhou F
    J Crit Care; 2021 Jun; 63():187-195. PubMed ID: 33012579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis.
    Fujii T; Ganeko R; Kataoka Y; Furukawa TA; Featherstone R; Doi K; Vincent JL; Pasero D; Robert R; Ronco C; Bagshaw SM
    Intensive Care Med; 2018 Feb; 44(2):167-178. PubMed ID: 29204670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymyxin B-immobilised haemoperfusion and mortality in critically ill patients with sepsis/septic shock: a protocol for a systematic review and meta-analysis.
    Fujii T; Ganeko R; Kataoka Y; Featherstone R; Bagshaw SM; Furukawa TA
    BMJ Open; 2016 Nov; 6(11):e012908. PubMed ID: 27872122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying Septic Shock Populations Benefitting From Polymyxin B Hemoperfusion: A Prospective Cohort Study Incorporating a Restricted Cubic Spline Regression Model.
    Nakata H; Yamakawa K; Kabata D; Umemura Y; Ogura H; Gando S; Shintani A; Shiraishi A; Saitoh D; Fujishima S; Mayumi T; Kushimoto S; Abe T; Shiino Y; Nakada TA; Tarui T; Hifumi T; Otomo Y; Okamoto K; Kotani J; Sakamoto Y; Sasaki J; Shiraishi SI; Takuma K; Tsuruta R; Hagiwara A; Masuno T; Takeyama N; Yamashita N; Ikeda H; Ueyama M; Fujimi S;
    Shock; 2020 Nov; 54(5):667-674. PubMed ID: 32195922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyxin B Hemoperfusion for Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.
    Terayama T; Yamakawa K; Umemura Y; Aihara M; Fujimi S
    Surg Infect (Larchmt); 2017 Apr; 18(3):225-233. PubMed ID: 28092497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion.
    Nakamura T; Sugaya T; Koide H
    Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of polymyxin B hemoperfusion on modulation of human leukocyte antigen DR in severe sepsis patients.
    Srisawat N; Tungsanga S; Lumlertgul N; Komaenthammasophon C; Peerapornratana S; Thamrongsat N; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S; Tungsanga K; Kellum JA
    Crit Care; 2018 Oct; 22(1):279. PubMed ID: 30367647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymyxin-B hemoperfusion in septic patients: analysis of a multicenter registry.
    Cutuli SL; Artigas A; Fumagalli R; Monti G; Ranieri VM; Ronco C; Antonelli M;
    Ann Intensive Care; 2016 Dec; 6(1):77. PubMed ID: 27502196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of polymyxin B hemoperfusion therapy on high endotoxin activity level patients after successful infection source control: a prospective cohort study.
    Lee WY; Kim HJ; Kim EY
    Sci Rep; 2021 Dec; 11(1):24132. PubMed ID: 34916567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C; Tomita M
    Shock; 2011 Oct; 36(4):332-8. PubMed ID: 21654557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study.
    Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H;
    Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials.
    Kuriyama A; Katsura M; Urushidani S; Takada T
    Ann Transl Med; 2018 Jun; 6(11):206. PubMed ID: 30023369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock.
    Kim JJ; Park YJ; Moon KY; Park JH; Jeong YK; Kim EY
    World J Gastrointest Surg; 2019 Dec; 11(12):422-432. PubMed ID: 31879534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of polymyxin B hemoperfusion on hemodynamics and prognosis in septic shock patients.
    Lee CT; Tu YK; Yeh YC; Chang T; Shih PY; Chao A; Huang HH; Cheng YJ; Yeh YC;
    J Crit Care; 2018 Feb; 43():202-206. PubMed ID: 28915395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.
    Okubo A; Nakashima A; Doi S; Ueno T; Sasaki K; Esaki T; Masaki T
    Clin Exp Nephrol; 2018 Oct; 22(5):1167-1173. PubMed ID: 29478200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Extended Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion on Hemodynamics, Vasoactive Substance Requirement, and Pulmonary Oxygenation in Patients with Sepsis: An Observational Study.
    Mitaka C; Kusao M; Kawagoe I; Satoh D; Iba T; Ronco C
    Blood Purif; 2022; 51(1):62-69. PubMed ID: 33910191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymyxin-B direct hemoperfusion (PMX-DHP) in gram negative sepsis].
    Perego AF; Morabito S; Graziani G; Casella GP; Parodi O
    G Ital Nefrol; 2006; 23 Suppl 36():S94-102. PubMed ID: 17068736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endotoxin adsorber hemoperfusion on sublingual microcirculation in patients with septic shock: a randomized controlled trial.
    Chen SH; Chan WS; Liu CM; Chiu CT; Chao A; Wu VC; Sheng WH; Lai CH; Wang MJ; Yeh YC
    Ann Intensive Care; 2020 Jun; 10(1):80. PubMed ID: 32533380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.
    Chang T; Tu YK; Lee CT; Chao A; Huang CH; Wang MJ; Yeh YC
    Crit Care Med; 2017 Aug; 45(8):e858-e864. PubMed ID: 28445237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.